Inhibition of Matrix Metalloproteinase and Hypertension

References

  1. 1

    Visse R, Nagase H : Matrix metalloproteinase and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827–839.

    CAS  Article  Google Scholar 

  2. 2

    Brew K, Dinakarpandian D, Nagase H : Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000; 1477: 267–283.

    CAS  Article  Google Scholar 

  3. 3

    Yu WHS, Yu S, Meng Q, et al: TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J Biol Chem 2000; 275: 31226–31232.

    CAS  Article  Google Scholar 

  4. 4

    Black RA, Rauch CT, Kozlosky CJ, et al: A metalloproteinase disintegrin that releases tumor necrosis factor-α from cells. Nature 1997; 385: 729–733.

    CAS  Article  Google Scholar 

  5. 5

    Singh RJR, Mason JC, Lidington EA, et al: Cytokine stimulated vascular cell adhesion molecules-1 (VCAM-1) ectomain release is regulated by TIMP-3. Cardiovasc Res 2005; 67: 39–49.

    CAS  Article  Google Scholar 

  6. 6

    Higuchi M, Yasuda O, Kawamoto H, et al: Tissue inhibitor of metalloproteinase-3 deficiency inhibits blood pressure elevation and myocardial microvascular remodeling induced by chronic administration of Nω-nitro-L-arginine methyl ester in mice. Hypertens Res 2007; 30: 563–571.

    CAS  Article  Google Scholar 

  7. 7

    Baker AH, Zaltsman AB, George SJ, et al: Divergent effects of tissue inhibitor of metalloporteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J Clin Invest 1998; 101: 1478–1487.

    CAS  Article  Google Scholar 

  8. 8

    Johnson TW, Wu YX, Herdeg C, et al: Stent-based derivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries. Arterioscler Thromb Vasc Biol 2005; 25: 754–759.

    CAS  Article  Google Scholar 

  9. 9

    Smookler DS, Mohammed FF, Kassiri Z, et al: Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation. J Immunol 2006; 176: 721–725.

    CAS  Article  Google Scholar 

  10. 10

    Ishiguro K, Sasamura H, Sakamaki Y, et al: Developmental activity of the renin-angiotensin system during the “critical period” modulates later L-NAME–induced hypertension and renal injury. Hypertens Res 2007; 30: 63–76.

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Takafumi Okura.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Okura, T., Higaki, J. Inhibition of Matrix Metalloproteinase and Hypertension. Hypertens Res 30, 477–478 (2007). https://doi.org/10.1291/hypres.30.477

Download citation

Keywords

  • matrix metalloproteinases (MMPs)
  • natural tissue inhibitors of MMP (TIMP)-3
  • hypertension
  • Nω-nitro-L-arginine methyl ester
  • a disintegrin and metalloproteinase (ADAM)17

Search